{
    "organizations": [],
    "uuid": "ad94549c8dbdb774e933a22eb14de693ddcc374f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pernix-announces-launch-of-authori/brief-pernix-announces-launch-of-authorized-generic-of-treximet-idUSFWN1Q61D7",
    "ord_in_thread": 0,
    "title": "BRIEF-Pernix Announces Launch Of Authorized Generic Of Treximet",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 16, 2018 / 9:06 PM / in 7 minutes BRIEF-Pernix Announces Launch Of Authorized Generic Of Treximet Reuters Staff 1 Min Read Feb 16 (Reuters) - Pernix Therapeutics Holdings Inc: * PERNIX THERAPEUTICS ANNOUNCES LAUNCH OF AUTHORIZED GENERIC VERSION OF TREXIMET® BY COMPANY’S SUBSIDIARY, MACOVEN PHARMACEUTICALS * PERNIX THERAPEUTICS HOLDINGS INC - ‍DESPITE LAUNCH OF AN AUTHORIZED GENERIC, PERNIX EXPECTS A SIGNIFICANT DECREASE IN SALES OF TREXIMET IN 2018​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-16T23:03:00.000+02:00",
    "crawled": "2018-02-16T23:15:10.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "announces",
        "launch",
        "authorized",
        "generic",
        "treximet",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "pernix",
        "therapeutic",
        "holding",
        "inc",
        "pernix",
        "therapeutic",
        "announces",
        "launch",
        "authorized",
        "generic",
        "version",
        "company",
        "subsidiary",
        "macoven",
        "pharmaceutical",
        "pernix",
        "therapeutic",
        "holding",
        "inc",
        "launch",
        "authorized",
        "generic",
        "pernix",
        "expects",
        "significant",
        "decrease",
        "sale",
        "treximet",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}